Exposure therapy triggers lasting reorganization of neural fear processing

A single session of exposure therapy can eliminate recalcitrant and disabling fear of phobogenic objects or situations. We studied neural mechanisms of this remarkable outcome by monitoring changes in brain activity as a result of successful 2-h treatment. Before treatment, phobogenic images excited...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 109; no. 23; pp. 9203 - 9208
Main Authors Hauner, Katherina K., Mineka, Susan, Voss, Joel L., Paller, Ken A.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 05.06.2012
National Acad Sciences
SeriesFrom the Cover
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A single session of exposure therapy can eliminate recalcitrant and disabling fear of phobogenic objects or situations. We studied neural mechanisms of this remarkable outcome by monitoring changes in brain activity as a result of successful 2-h treatment. Before treatment, phobogenic images excited activity in a network of regions, including amygdala, ínsula, and cingulate cortex, relative to neutral images. Successful therapy dampened responsiveness in this fear-sensitive network while concomitantly heightening prefrontal involvement. Six months later, dampened fear-network activity persisted but without prefrontal engagement. Additionally, individual differences in the magnitude of visual cortex activations recorded shortly after therapy predicted therapeutic outcomes 6 mo later, which involved persistently diminished visual responsiveness to phobogenic images. Successful therapy thus entailed stable reorganization of neural responses to initially feared stimuli. These effects were linked to fear-extinction mechanisms identified in animal models, thus opening new opportunities for the treatment and prevention of debilitating anxiety disorders.
AbstractList A single session of exposure therapy can eliminate recalcitrant and disabling fear of phobogenic objects or situations. We studied neural mechanisms of this remarkable outcome by monitoring changes in brain activity as a result of successful 2-h treatment. Before treatment, phobogenic images excited activity in a network of regions, including amygdala, insula, and cingulate cortex, relative to neutral images. Successful therapy dampened responsiveness in this fear-sensitive network while concomitantly heightening prefrontal involvement. Six months later, dampened fear-network activity persisted but without prefrontal engagement. Additionally, individual differences in the magnitude of visual cortex activations recorded shortly after therapy predicted therapeutic outcomes 6 mo later, which involved persistently diminished visual responsiveness to phobogenic images. Successful therapy thus entailed stable reorganization of neural responses to initially feared stimuli. These effects were linked to fear-extinction mechanisms identified in animal models, thus opening new opportunities for the treatment and prevention of debilitating anxiety disorders.
A single session of exposure therapy can eliminate recalcitrant and disabling fear of phobogenic objects or situations. We studied neural mechanisms of this remarkable outcome by monitoring changes in brain activity as a result of successful 2-h treatment. Before treatment, phobogenic images excited activity in a network of regions, including amygdala, insula, and cingulate cortex, relative to neutral images. Successful therapy dampened responsiveness in this fear-sensitive network while concomitantly heightening prefrontal involvement. Six months later, dampened fear-network activity persisted but without prefrontal engagement. Additionally, individual differences in the magnitude of visual cortex activations recorded shortly after therapy predicted therapeutic outcomes 6 mo later, which involved persistently diminished visual responsiveness to phobogenic images. Successful therapy thus entailed stable reorganization of neural responses to initially feared stimuli. These effects were linked to fear-extinction mechanisms identified in animal models, thus opening new opportunities for the treatment and prevention of debilitating anxiety disorders. [PUBLICATION ABSTRACT]
A single session of exposure therapy can eliminate recalcitrant and disabling fear of phobogenic objects or situations. We studied neural mechanisms of this remarkable outcome by monitoring changes in brain activity as a result of successful 2-h treatment. Before treatment, phobogenic images excited activity in a network of regions, including amygdala, ínsula, and cingulate cortex, relative to neutral images. Successful therapy dampened responsiveness in this fear-sensitive network while concomitantly heightening prefrontal involvement. Six months later, dampened fear-network activity persisted but without prefrontal engagement. Additionally, individual differences in the magnitude of visual cortex activations recorded shortly after therapy predicted therapeutic outcomes 6 mo later, which involved persistently diminished visual responsiveness to phobogenic images. Successful therapy thus entailed stable reorganization of neural responses to initially feared stimuli. These effects were linked to fear-extinction mechanisms identified in animal models, thus opening new opportunities for the treatment and prevention of debilitating anxiety disorders.
A single session of exposure therapy can eliminate recalcitrant and disabling fear of phobogenic objects or situations. We studied neural mechanisms of this remarkable outcome by monitoring changes in brain activity as a result of successful 2-h treatment. Before treatment, phobogenic images excited activity in a network of regions, including amygdala, insula, and cingulate cortex, relative to neutral images. Successful therapy dampened responsiveness in this fear-sensitive network while concomitantly heightening prefrontal involvement. Six months later, dampened fear-network activity persisted but without prefrontal engagement. Additionally, individual differences in the magnitude of visual cortex activations recorded shortly after therapy predicted therapeutic outcomes 6 mo later, which involved persistently diminished visual responsiveness to phobogenic images. Successful therapy thus entailed stable reorganization of neural responses to initially feared stimuli. These effects were linked to fear-extinction mechanisms identified in animal models, thus opening new opportunities for the treatment and prevention of debilitating anxiety disorders.A single session of exposure therapy can eliminate recalcitrant and disabling fear of phobogenic objects or situations. We studied neural mechanisms of this remarkable outcome by monitoring changes in brain activity as a result of successful 2-h treatment. Before treatment, phobogenic images excited activity in a network of regions, including amygdala, insula, and cingulate cortex, relative to neutral images. Successful therapy dampened responsiveness in this fear-sensitive network while concomitantly heightening prefrontal involvement. Six months later, dampened fear-network activity persisted but without prefrontal engagement. Additionally, individual differences in the magnitude of visual cortex activations recorded shortly after therapy predicted therapeutic outcomes 6 mo later, which involved persistently diminished visual responsiveness to phobogenic images. Successful therapy thus entailed stable reorganization of neural responses to initially feared stimuli. These effects were linked to fear-extinction mechanisms identified in animal models, thus opening new opportunities for the treatment and prevention of debilitating anxiety disorders.
Author Hauner, Katherina K.
Voss, Joel L.
Paller, Ken A.
Mineka, Susan
Author_xml – sequence: 1
  givenname: Katherina K.
  surname: Hauner
  fullname: Hauner, Katherina K.
– sequence: 2
  givenname: Susan
  surname: Mineka
  fullname: Mineka, Susan
– sequence: 3
  givenname: Joel L.
  surname: Voss
  fullname: Voss, Joel L.
– sequence: 4
  givenname: Ken A.
  surname: Paller
  fullname: Paller, Ken A.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22623532$$D View this record in MEDLINE/PubMed
BookMark eNp9kb1vFDEQxS0URC6BmgpYKQ3NJmN712s3kVAUvhSJBmrLtzfe-LRnL7YXEf76-LjjAilo7GJ-b_ye3wk58sEjIS8pnFPo-MXkTTqnDFrWMArqCVmUk9aiUXBEFgCsq2XDmmNyktIaAFQr4Rk5Zkww3nK2IJ-vf04hzRGrfIvRTHdVjm4YMKZqNCk7P1QRQxyMd79MdsFXwVYe52jGyqKJ1RRDjykV8Dl5as2Y8MX-PiXf3l9_vfpY33z58Onq3U3dN6LL9RJaVIJJUyxY1gqjhBF8BY1lVMoeqbIrSXvVWWYRlWKKd2jskq6WJZpR_JRc7vZO83KDqx59Lm70FN3GxDsdjNP_Try71UP4oTmXDZVdWfB2vyCG7zOmrDcu9TiOxmOYk6ZAFSgJShT07BG6DnP0Jd6WkkoKRZtCvf7b0cHKn28uwMUO6GNIKaI9IBT0tki9LVI_FFkU7SNF7_LvAkokN_5H92ZvZTt4eEVpxrViwAvxakesUw7xgDRUAIeu5ffnErcL
CitedBy_id crossref_primary_10_1038_s41398_020_00887_2
crossref_primary_10_1097_PSY_0000000000000646
crossref_primary_10_3389_fpsyg_2022_853804
crossref_primary_10_3758_s13415_016_0440_5
crossref_primary_10_3389_fnbeh_2015_00148
crossref_primary_10_1002_brb3_1157
crossref_primary_10_1007_s10615_018_0676_3
crossref_primary_10_1016_j_yebeh_2013_10_014
crossref_primary_10_1016_j_pharmthera_2014_12_004
crossref_primary_10_1177_1039856215598868
crossref_primary_10_1145_3474685
crossref_primary_10_1176_appi_focus_12_3_290
crossref_primary_10_1038_nrn3524
crossref_primary_10_3390_s22051845
crossref_primary_10_1002_jts_22918
crossref_primary_10_1016_j_neubiorev_2020_05_005
crossref_primary_10_1002_da_22583
crossref_primary_10_1097_HRP_0000000000000132
crossref_primary_10_1159_000511096
crossref_primary_10_1017_S0033291721002270
crossref_primary_10_3758_s13415_023_01080_w
crossref_primary_10_1016_j_janxdis_2020_102344
crossref_primary_10_1016_j_jphysparis_2014_04_003
crossref_primary_10_1038_npp_2017_83
crossref_primary_10_1093_scan_nsu141
crossref_primary_10_1016_j_bbr_2017_02_016
crossref_primary_10_1016_j_neubiorev_2014_10_016
crossref_primary_10_1016_j_tins_2012_11_003
crossref_primary_10_35430_nab_2021_e16
crossref_primary_10_1016_j_yfrne_2022_101030
crossref_primary_10_15703_kjc_16_2_201504_27
crossref_primary_10_1016_j_cobeha_2018_04_010
crossref_primary_10_1038_npp_2015_255
crossref_primary_10_4085_1062_6050_0215_23
crossref_primary_10_1016_j_ijchp_2022_100342
crossref_primary_10_1038_npp_2015_174
crossref_primary_10_1016_j_bbr_2024_115409
crossref_primary_10_1016_j_brat_2016_08_015
crossref_primary_10_1016_j_cpr_2019_04_001
crossref_primary_10_1080_00029157_2017_1326372
crossref_primary_10_1007_s00702_024_02754_6
crossref_primary_10_1016_j_brat_2019_04_007
crossref_primary_10_1016_j_biopsych_2013_11_008
crossref_primary_10_30773_pi_2018_08_31
crossref_primary_10_1038_nn_3582
crossref_primary_10_1371_journal_pone_0074657
crossref_primary_10_1016_j_biopsych_2019_05_017
crossref_primary_10_1002_iub_1310
crossref_primary_10_1111_pcn_13774
crossref_primary_10_1016_j_neubiorev_2016_04_005
crossref_primary_10_1016_j_neubiorev_2019_12_009
crossref_primary_10_1093_scan_nsy044
crossref_primary_10_1038_npp_2016_207
crossref_primary_10_3389_fnhum_2016_00340
crossref_primary_10_1101_lm_028902_112
crossref_primary_10_1002_brb3_1766
crossref_primary_10_1016_j_pscychresns_2020_111066
crossref_primary_10_1016_j_biopsych_2024_07_010
crossref_primary_10_1073_pnas_1305706110
crossref_primary_10_1080_10503307_2014_883088
crossref_primary_10_1177_0963721417716928
crossref_primary_10_1016_j_neuropharm_2022_109380
crossref_primary_10_1145_3474675
crossref_primary_10_1016_j_jocrd_2015_01_006
crossref_primary_10_1016_j_neubiorev_2022_104895
Cites_doi 10.1016/S1053-8119(02)00030-7
10.1146/annurev.neuro.23.1.315
10.1007/s00406-007-0754-y
10.3758/CABN.5.4.373
10.1162/089892902760807212
10.1126/science.287.5451.248
10.1016/j.biopsych.2005.10.012
10.1016/j.cpr.2007.01.003
10.1002/hipo.20608
10.1146/annurev.psych.55.090902.142050
10.1002/hipo.10018
10.1038/nn1314
10.1016/j.biopsycho.2006.01.006
10.1016/j.biopsych.2006.10.011
10.1016/j.neuron.2008.06.029
10.1016/j.neuroimage.2005.07.007
10.1016/0146-6402(93)90012-Q
10.1016/j.cpr.2010.01.003
10.1023/A:1025048802629
10.1038/npp.2011.115
10.1016/j.biopsych.2006.03.010
10.1016/j.neuroimage.2008.09.037
10.1016/j.neuroimage.2007.05.023
10.1038/npp.2009.121
10.1016/j.beth.2005.04.001
10.1006/cbmr.1996.0014
10.1037/0022-006X.67.4.599
10.1016/S0005-7894(74)80008-0
10.1016/j.cpr.2004.08.005
10.1016/0166-4328(93)90091-4
10.1016/j.neuron.2004.08.042
10.1016/S0005-7967(99)00176-X
10.1016/j.biopsych.2007.04.024
10.1016/S0005-7894(05)80385-5
10.1016/j.beth.2007.07.003
10.1016/j.bbr.2011.04.025
ContentType Journal Article
Copyright copyright © 1993-2008 National Academy of Sciences of the United States of America
Copyright National Academy of Sciences Jun 5, 2012
Copyright_xml – notice: copyright © 1993-2008 National Academy of Sciences of the United States of America
– notice: Copyright National Academy of Sciences Jun 5, 2012
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QG
7QL
7QP
7QR
7SN
7SS
7T5
7TK
7TM
7TO
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7X8
5PM
DOI 10.1073/pnas.1205242109
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Nucleic Acids Abstracts
Ecology Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
Entomology Abstracts
Genetics Abstracts
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Immunology Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
Virology and AIDS Abstracts


MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
DocumentTitleAlternate Exposure therapy triggers lasting neural changes
EISSN 1091-6490
EndPage 9208
ExternalDocumentID PMC3384187
2680382551
22623532
10_1073_pnas_1205242109
109_23_9203
41603075
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
Feature
GrantInformation_xml – fundername: NINDS NIH HHS
  grantid: T32 NS047987
GroupedDBID ---
-DZ
-~X
.55
0R~
123
29P
2AX
2FS
2WC
4.4
53G
5RE
5VS
85S
AACGO
AAFWJ
AANCE
ABBHK
ABOCM
ABPLY
ABPPZ
ABTLG
ABXSQ
ABZEH
ACGOD
ACHIC
ACIWK
ACNCT
ACPRK
ADQXQ
ADULT
ADXHL
AENEX
AEUPB
AEXZC
AFFNX
AFOSN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AQVQM
BKOMP
CS3
D0L
DCCCD
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HH5
HTVGU
HYE
IPSME
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
KQ8
L7B
LU7
MVM
N9A
N~3
O9-
OK1
P-O
PNE
PQQKQ
R.V
RHI
RNA
RNS
RPM
RXW
SA0
SJN
TAE
TN5
UKR
W8F
WH7
WOQ
WOW
X7M
XSW
Y6R
YBH
YKV
YSK
ZCA
~02
~KM
-
02
0R
1AW
55
AAPBV
ABFLS
ABPTK
ADACO
ADZLD
AJYGW
ASUFR
DNJUQ
DOOOF
DWIUU
DZ
F20
JSODD
KM
PQEST
RHF
VQA
X
XHC
ZA5
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QG
7QL
7QP
7QR
7SN
7SS
7T5
7TK
7TM
7TO
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7X8
5PM
ID FETCH-LOGICAL-c467t-b05e9628a623f256a96a63d04f2188ce19fd81c97f2fee992937eafb1db091a93
ISSN 0027-8424
1091-6490
IngestDate Thu Aug 21 18:36:20 EDT 2025
Fri Jul 11 05:22:51 EDT 2025
Mon Jun 30 08:27:48 EDT 2025
Mon Jul 21 05:52:17 EDT 2025
Tue Jul 01 03:39:18 EDT 2025
Thu Apr 24 22:55:32 EDT 2025
Wed Nov 11 00:30:03 EST 2020
Thu May 29 08:40:48 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 23
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c467t-b05e9628a623f256a96a63d04f2188ce19fd81c97f2fee992937eafb1db091a93
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
Edited by Mortimer Mishkin, National Institute of Mental Health, Bethesda, MD, and approved April 24, 2012 (received for review March 28, 2012)
Author contributions: K.K.H., S.M., J.L.V., and K.A.P. designed research; K.K.H. performed research; K.K.H. analyzed data; and K.K.H., S.M., J.L.V., and K.A.P. wrote the paper.
OpenAccessLink https://www.pnas.org/content/pnas/109/23/9203.full.pdf
PMID 22623532
PQID 1018986914
PQPubID 42026
PageCount 6
ParticipantIDs crossref_primary_10_1073_pnas_1205242109
proquest_journals_1018986914
crossref_citationtrail_10_1073_pnas_1205242109
jstor_primary_41603075
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3384187
pubmed_primary_22623532
proquest_miscellaneous_1019098096
pnas_primary_109_23_9203
ProviderPackageCode RNA
PNE
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-06-05
PublicationDateYYYYMMDD 2012-06-05
PublicationDate_xml – month: 06
  year: 2012
  text: 2012-06-05
  day: 05
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Washington
PublicationSeriesTitle From the Cover
PublicationTitle Proceedings of the National Academy of Sciences - PNAS
PublicationTitleAlternate Proc Natl Acad Sci U S A
PublicationYear 2012
Publisher National Academy of Sciences
National Acad Sciences
Publisher_xml – name: National Academy of Sciences
– name: National Acad Sciences
References Craske MG (e_1_3_3_5_2) 2006
e_1_3_3_16_2
Wolpe J (e_1_3_3_36_2) 1973
e_1_3_3_19_2
e_1_3_3_38_2
e_1_3_3_18_2
e_1_3_3_39_2
e_1_3_3_13_2
e_1_3_3_12_2
e_1_3_3_37_2
e_1_3_3_15_2
LeDoux JE (e_1_3_3_17_2) 1996
e_1_3_3_34_2
e_1_3_3_14_2
e_1_3_3_32_2
e_1_3_3_33_2
e_1_3_3_11_2
e_1_3_3_30_2
e_1_3_3_10_2
e_1_3_3_31_2
e_1_3_3_40_2
American Psychiatric Association (e_1_3_3_1_2) 2000
First MB (e_1_3_3_35_2) 2002
e_1_3_3_6_2
e_1_3_3_8_2
e_1_3_3_7_2
e_1_3_3_28_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_24_2
e_1_3_3_23_2
e_1_3_3_26_2
e_1_3_3_25_2
e_1_3_3_2_2
e_1_3_3_20_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_41_2
e_1_3_3_3_2
e_1_3_3_21_2
8136051 - Behav Brain Res. 1993 Dec 20;58(1-2):69-79
19710632 - Neuropsychopharmacology. 2010 Jan;35(1):136-46
8812068 - Comput Biomed Res. 1996 Jun;29(3):162-73
17292521 - Clin Psychol Rev. 2007 Jul;27(6):750-9
17217927 - Biol Psychiatry. 2007 Sep 1;62(5):446-54
10845067 - Annu Rev Neurosci. 2000;23:315-41
17902000 - Eur Arch Psychiatry Clin Neurosci. 2007 Dec;257(8):486-93
18721635 - Behav Ther. 2008 Sep;39(3):207-23
16712801 - Biol Psychiatry. 2006 Aug 15;60(4):337-43
12595193 - Neuroimage. 2003 Feb;18(2):401-9
14744210 - Annu Rev Psychol. 2004;55:51-86
18976717 - Neuroimage. 2009 Feb 1;44(3):839-48
10634773 - Science. 2000 Jan 14;287(5451):248-51
15363399 - Neuron. 2004 Sep 16;43(6):897-905
16087353 - Neuroimage. 2006 Jan 1;29(1):125-35
17706612 - Biol Psychiatry. 2007 Nov 15;62(10):1119-25
12495527 - J Cogn Neurosci. 2002 Nov 15;14(8):1215-29
11153971 - Behav Res Ther. 2001 Feb;39(2):167-83
16412988 - Biol Psychiatry. 2006 Aug 15;60(4):329-36
19405122 - Hippocampus. 2009 Sep;19(9):773-8
21536077 - Behav Brain Res. 2011 Oct 1;223(2):403-10
14514027 - Cell Mol Neurobiol. 2003 Oct;23(4-5):727-38
16541808 - Cogn Affect Behav Neurosci. 2005 Dec;5(4):373-87
12099487 - Hippocampus. 2002;12(3):363-76
18786365 - Neuron. 2008 Sep 11;59(5):829-38
20381224 - Clin Psychol Rev. 2010 Jul;30(5):467-78
17588776 - Neuroimage. 2007 Aug 15;37(2):652-62
21750582 - Neuropsychopharmacology. 2011 Oct;36(11):2276-85
15361879 - Nat Neurosci. 2004 Oct;7(10):1144-52
10450633 - J Consult Clin Psychol. 1999 Aug;67(4):599-604
15596081 - Clin Psychol Rev. 2005 Jan;25(1):67-95
16472906 - Biol Psychol. 2006 Jul;73(1):39-48
16942960 - Behav Ther. 2006 Mar;37(1):49-60
References_xml – ident: e_1_3_3_31_2
  doi: 10.1016/S1053-8119(02)00030-7
– ident: e_1_3_3_24_2
  doi: 10.1146/annurev.neuro.23.1.315
– volume-title: Diagnostic and Statistical Manual of Mental Disorders
  year: 2000
  ident: e_1_3_3_1_2
– ident: e_1_3_3_33_2
  doi: 10.1007/s00406-007-0754-y
– ident: e_1_3_3_25_2
  doi: 10.3758/CABN.5.4.373
– ident: e_1_3_3_23_2
  doi: 10.1162/089892902760807212
– ident: e_1_3_3_13_2
  doi: 10.1126/science.287.5451.248
– ident: e_1_3_3_11_2
  doi: 10.1016/j.biopsych.2005.10.012
– ident: e_1_3_3_6_2
  doi: 10.1016/j.cpr.2007.01.003
– ident: e_1_3_3_41_2
  doi: 10.1002/hipo.20608
– ident: e_1_3_3_12_2
  doi: 10.1146/annurev.psych.55.090902.142050
– ident: e_1_3_3_40_2
  doi: 10.1002/hipo.10018
– ident: e_1_3_3_9_2
  doi: 10.1038/nn1314
– ident: e_1_3_3_7_2
  doi: 10.1016/j.biopsycho.2006.01.006
– ident: e_1_3_3_14_2
  doi: 10.1016/j.biopsych.2006.10.011
– ident: e_1_3_3_27_2
  doi: 10.1016/j.neuron.2008.06.029
– ident: e_1_3_3_32_2
  doi: 10.1016/j.neuroimage.2005.07.007
– ident: e_1_3_3_19_2
  doi: 10.1016/0146-6402(93)90012-Q
– ident: e_1_3_3_34_2
  doi: 10.1016/j.cpr.2010.01.003
– ident: e_1_3_3_8_2
  doi: 10.1023/A:1025048802629
– ident: e_1_3_3_26_2
  doi: 10.1038/npp.2011.115
– ident: e_1_3_3_10_2
  doi: 10.1016/j.biopsych.2006.03.010
– ident: e_1_3_3_39_2
  doi: 10.1016/j.neuroimage.2008.09.037
– ident: e_1_3_3_21_2
  doi: 10.1016/j.neuroimage.2007.05.023
– ident: e_1_3_3_22_2
  doi: 10.1038/npp.2009.121
– volume-title: Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I/NP)
  year: 2002
  ident: e_1_3_3_35_2
– ident: e_1_3_3_37_2
  doi: 10.1016/j.beth.2005.04.001
– ident: e_1_3_3_38_2
  doi: 10.1006/cbmr.1996.0014
– volume-title: Fear and Learning: Basic Science to Clinical Application
  year: 2006
  ident: e_1_3_3_5_2
– ident: e_1_3_3_18_2
  doi: 10.1037/0022-006X.67.4.599
– ident: e_1_3_3_20_2
  doi: 10.1016/S0005-7894(74)80008-0
– ident: e_1_3_3_29_2
  doi: 10.1016/j.cpr.2004.08.005
– ident: e_1_3_3_16_2
  doi: 10.1016/0166-4328(93)90091-4
– ident: e_1_3_3_15_2
  doi: 10.1016/j.neuron.2004.08.042
– ident: e_1_3_3_2_2
  doi: 10.1016/S0005-7967(99)00176-X
– volume-title: The Emotional Brain
  year: 1996
  ident: e_1_3_3_17_2
– volume-title: The Practice of Behavior Therapy
  year: 1973
  ident: e_1_3_3_36_2
– ident: e_1_3_3_30_2
  doi: 10.1016/j.biopsych.2007.04.024
– ident: e_1_3_3_3_2
  doi: 10.1016/S0005-7894(05)80385-5
– ident: e_1_3_3_4_2
  doi: 10.1016/j.beth.2007.07.003
– ident: e_1_3_3_28_2
  doi: 10.1016/j.bbr.2011.04.025
– reference: 16712801 - Biol Psychiatry. 2006 Aug 15;60(4):337-43
– reference: 19710632 - Neuropsychopharmacology. 2010 Jan;35(1):136-46
– reference: 15596081 - Clin Psychol Rev. 2005 Jan;25(1):67-95
– reference: 20381224 - Clin Psychol Rev. 2010 Jul;30(5):467-78
– reference: 10845067 - Annu Rev Neurosci. 2000;23:315-41
– reference: 8136051 - Behav Brain Res. 1993 Dec 20;58(1-2):69-79
– reference: 16942960 - Behav Ther. 2006 Mar;37(1):49-60
– reference: 11153971 - Behav Res Ther. 2001 Feb;39(2):167-83
– reference: 16087353 - Neuroimage. 2006 Jan 1;29(1):125-35
– reference: 17706612 - Biol Psychiatry. 2007 Nov 15;62(10):1119-25
– reference: 16472906 - Biol Psychol. 2006 Jul;73(1):39-48
– reference: 18721635 - Behav Ther. 2008 Sep;39(3):207-23
– reference: 17902000 - Eur Arch Psychiatry Clin Neurosci. 2007 Dec;257(8):486-93
– reference: 16412988 - Biol Psychiatry. 2006 Aug 15;60(4):329-36
– reference: 19405122 - Hippocampus. 2009 Sep;19(9):773-8
– reference: 12595193 - Neuroimage. 2003 Feb;18(2):401-9
– reference: 18976717 - Neuroimage. 2009 Feb 1;44(3):839-48
– reference: 14744210 - Annu Rev Psychol. 2004;55:51-86
– reference: 8812068 - Comput Biomed Res. 1996 Jun;29(3):162-73
– reference: 17217927 - Biol Psychiatry. 2007 Sep 1;62(5):446-54
– reference: 10450633 - J Consult Clin Psychol. 1999 Aug;67(4):599-604
– reference: 12495527 - J Cogn Neurosci. 2002 Nov 15;14(8):1215-29
– reference: 17588776 - Neuroimage. 2007 Aug 15;37(2):652-62
– reference: 21750582 - Neuropsychopharmacology. 2011 Oct;36(11):2276-85
– reference: 17292521 - Clin Psychol Rev. 2007 Jul;27(6):750-9
– reference: 10634773 - Science. 2000 Jan 14;287(5451):248-51
– reference: 21536077 - Behav Brain Res. 2011 Oct 1;223(2):403-10
– reference: 12099487 - Hippocampus. 2002;12(3):363-76
– reference: 14514027 - Cell Mol Neurobiol. 2003 Oct;23(4-5):727-38
– reference: 18786365 - Neuron. 2008 Sep 11;59(5):829-38
– reference: 15363399 - Neuron. 2004 Sep 16;43(6):897-905
– reference: 16541808 - Cogn Affect Behav Neurosci. 2005 Dec;5(4):373-87
– reference: 15361879 - Nat Neurosci. 2004 Oct;7(10):1144-52
SSID ssj0009580
Score 2.3449242
Snippet A single session of exposure therapy can eliminate recalcitrant and disabling fear of phobogenic objects or situations. We studied neural mechanisms of this...
SourceID pubmedcentral
proquest
pubmed
crossref
pnas
jstor
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 9203
SubjectTerms Adolescent
Adult
Amygdala
Amygdala - physiology
Analysis of Variance
Animal models
Anxiety disorders
Arachnophobia
Behavioral neuroscience
Biological Sciences
Brain
Brain Mapping
Claustrophobia
Emotions
Extinction, Psychological - physiology
Fear
Fear & phobias
Fear - physiology
Fear - psychology
Female
Humans
Implosive Therapy - methods
Linear Models
Magnetic Resonance Imaging
Male
Mental disorders
Neurons
NMR
Nuclear magnetic resonance
Phobias
Phobic Disorders - therapy
Photic Stimulation
Prefrontal Cortex - physiology
Psychotherapy
Spiders
Visual cortex
Title Exposure therapy triggers lasting reorganization of neural fear processing
URI https://www.jstor.org/stable/41603075
http://www.pnas.org/content/109/23/9203.abstract
https://www.ncbi.nlm.nih.gov/pubmed/22623532
https://www.proquest.com/docview/1018986914
https://www.proquest.com/docview/1019098096
https://pubmed.ncbi.nlm.nih.gov/PMC3384187
Volume 109
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbKeOEFMWAsMJCReBiqUhLHceLHqhqqClR92NDeIidxGALSam0lxF_Kn8Od7fzoKAj2UrXJJWl8X-7Oznd3hLwquZYlx9fuIoEJioiVL3Va-bJiKi5KgTW6kG0xF9MLPruMLweDnz3W0naTj4ofe_NKbqNV2AZ6xSzZ_9Bse1LYAN9Bv_AJGobPf9Lx2ffVElf4hjaLCgJJmGt_wpRciIkNn_laL3vJloa1oU2hjcrUuLZZAo33cjHqovVp64ZBMG-WDMddAoqzCuuhP1zMu3bGU7WtO6IGJheq4btRq1cIar-o3-hAH13v9hkSbd-30gvVJCqCPxiO7XYcWb3GdBWbFzNBEmp_8QJZIMIP4o7b8Zd_37faDDwpt7nWI20NNcQ5vuC21WhryQPZgyyLeoZZsiDqOXn4me51IGDxsOtxrdajkAUxvjC3J-3BafXN4AkCVxbFbnV2t2b34sMEpv48TJM75C6DCQwzLqNfDjq1yVHuzpqiU0n05sa1sVq1u9BO6GTZs1iSF-T3TY9usnx7YdP5A3LfzXfo2IL3kAx0_ZAcNqNPT13Z89ePyKxBM3Vopg2aqUMz3UUzXVbUopkimmmH5sfk4u3Z-WTqu04ffgGOeuPnQaylYKmCG60gCFdSKBGVAa8gAk0LHcqqTMNCJhWrtJYQ0keJVlUeljngQMnoiBzUy1ofEyoY00mYqzivOI_KEKSKuCx4GegEw2ePjJpBzApXBh-7sXzNDB0jiTIc0KxTgEdO2wNWtgLMn0WPjFZaOY5N3CEo98ixEe2OlxmLMgSlR04a1WXOtKyRd5nKVMiQe-RluxsMP77NU7Vebo2MDGQaSOGRJ1bT7fkbxHgk2cFAK4BF5Xf31J-vTHF5h9untz7yGbnXPekn5GBzvdXPIXDf5C_MM_ALmrTvQw
linkProvider ABC ChemistRy
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exposure+therapy+triggers+lasting+reorganization+of+neural+fear+processing&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Hauner%2C+Katherina+K.&rft.au=Mineka%2C+Susan&rft.au=Voss%2C+Joel+L.&rft.au=Paller%2C+Ken+A.&rft.series=From+the+Cover&rft.date=2012-06-05&rft.pub=National+Academy+of+Sciences&rft.issn=0027-8424&rft.eissn=1091-6490&rft.volume=109&rft.issue=23&rft.spage=9203&rft.epage=9208&rft_id=info:doi/10.1073%2Fpnas.1205242109&rft_id=info%3Apmid%2F22623532&rft.externalDocID=PMC3384187
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F109%2F23.cover.gif
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F109%2F23.cover.gif